{"disease":{"id":"batten-disease","name":"batten disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06203106","title":"NYSCF Scientific Discovery Biobank","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"New York Stem Cell Foundation Research Institute","has_results":false},{"nct_id":"NCT05007990","title":"Caregiving Networks Across Disease Context and the Life Course","phase":"","overall_status":"RECRUITING","enrollment_count":2800,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT04613089","title":"Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT03307304","title":"Investigations of Juvenile Neuronal Ceroid Lipofuscinosis","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT04461561","title":"Using NPT to Evaluate Providing PPC as ELNEC-PPC WBT for Nurses","phase":"NA","overall_status":"UNKNOWN","enrollment_count":172,"lead_sponsor_name":"Altoosi University College","has_results":false},{"nct_id":"NCT02678689","title":"A Safety, Tolerability, and Efficacy Study of BMN 190 in Pediatric Patients < 18 Years of Age With CLN2 Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"BioMarin Pharmaceutical","has_results":true},{"nct_id":"NCT01161576","title":"Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis (LINCL)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT04644549","title":"Natural History Study of Batten Disease","phase":"","overall_status":"TERMINATED","enrollment_count":10,"lead_sponsor_name":"Emily de los Reyes","has_results":false},{"nct_id":"NCT01414985","title":"AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT03770572","title":"Gene Therapy for Children With CLN3 Batten Disease","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":7,"lead_sponsor_name":"Alcyone Therapeutics, Inc","has_results":false},{"nct_id":"NCT05174039","title":"An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of Subjects With Batten Ceroid Lipofuscinosis, Neuronal 3 (CLN3) Disease","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Beyond Batten Disease Foundation","has_results":true}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}